Fundz

Transplant Genomics Inc. reported raising $3.17 Million in an initial SEC Form D filing, from an offering of $5.53 Million

PRIVATEApr 05, 2017$3.2M of $5.5M raised

Amount Raised

$3.17 Million

$3.17 Million sold, per SEC Form D (first sale Apr 5, 2017)

Round Type

Seed

MansfieldOtherBiotechnologyHealthcare

Quick answer

Transplant Genomics Inc. raised $3.17 Million in a Seed round, dated April 5, 2017. Transplant Genomics Inc. is based in Mansfield, Massachusetts, United States.

How much did Transplant Genomics Inc. raise?
Transplant Genomics Inc. raised $3.17 Million in a Seed round on April 5, 2017.
What does Transplant Genomics Inc. do?
Transplant Genomics is a biotech company that focuses on improving organ transplant outcomes.
Where is Transplant Genomics Inc. based and how big is it?
Transplant Genomics Inc. is based in Mansfield, Massachusetts, United States.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as Transplant Genomics Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Northwest Biotherapeutics raised $52K (Pre-Seed) on May 17, 2017.
  • Cue Health raised $15M on May 16, 2017.
  • Elite Pharmaceuticals raised $800K (Seed) on May 10, 2017.
  • Treace raised $5.9M on May 10, 2017.
  • Infinite Arthroscopy Inc., Ltd raised an undisclosed amount on May 9, 2017.
  • Optimvia raised an undisclosed amount on May 8, 2017.

Who to call at Transplant Genomics Inc., and when

A new round usually means Transplant Genomics Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Transplant Genomics Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Transplant Genomics Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Transplant Genomics Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Transplant Genomics Inc.

Location

Mansfield, Massachusetts, United States

About

Transplant Genomics is a biotech company that focuses on improving organ transplant outcomes.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Transplant Genomics Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Transplant Genomics Inc.'s next move

See what Strategic adds

Transplant Genomics Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.